We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lonza, Forty Seven Manufacturing Agreement

News   Oct 13, 2016

 
Lonza, Forty Seven Manufacturing Agreement
 
 
Advertisement
 

RELATED ARTICLES

Probiotic Yeast Engineered To Produce Beta-Carotene

News

In order to produce beta-carotene in the guts of laboratory mice, researchers have genetically engineered a probiotic yeast. The advance demonstrates the utility of work the researchers have done to detail how a suite of genetic engineering tools can be used to modify the yeast.

READ MORE

Conserved Antibody Binding-Site Identified Across COVID-19 Variants

News

Scientists have uncovered the first full structure of the coronavirus nucleocapsid (N) protein and discovered how antibodies from COVID-19 patients interact with it. They also determined that the structure appears similar across many coronaviruses, including recent COVID-19 variants — making it an ideal target for advanced treatments and vaccines.

READ MORE

Prioritizing Drugs Targeting IFNAR2 and ACE2 To Treat COVID-19

News

Researchers have used human genetics in a new study and the findings suggest researchers should prioritize clinical trials of drugs that target the proteins IFNAR2 and ACE2 to manage COVID-19 in its early stages.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE